Alere received exclusive, worldwide rights to develop and commercialize VitaPath's spina bifida risk assessment assay

VitaPath Genetics Inc.

U.S. / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Alere Inc.

U.S. / Medical Devices and Diagnostics

$2,105.7m on 08/12/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced